Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting, 7484-7485 [2010-3201]
Download as PDF
<![CDATA[
7484
Federal Register / Vol. 75, No. 33 / Friday, February 19, 2010 / Notices
pwalker on DSK8KYBLC1PROD with NOTICES
Services Administration’s (SAMHSA)
Drug Testing Advisory Board (DTAB)
will meet on March 8, 2010.
The meeting is open to the public and will
include discussion of the Mandatory
Guidelines for Federal Workplace Drug
Testing Programs, including implementation
of the revised Mandatory Guidelines; Federal
drug testing updates from the Department of
Transportation (DOT), the Department of
Defense, and the Nuclear Regulatory
Commission; review of significant changes in
the revised Mandatory Guidelines; review of
the National Laboratory Certification Program
planned implementation of the revised
Mandatory Guidelines; an update on the
revised Federal Custody and Control Form; a
review of the special proficiency testing
program for initial and confirmation testing
for new analytes and new cutoffs; an update
on instrumented initial test facilities; an
update on the DTAB working groups; and a
comparison of HHS and DOT urine collection
requirements.
DTAB members and invited presenters will
participate in this meeting through remote
internet connection. On-site attendance by
the public will be limited to space available.
The meeting can also be accessed by the
public via teleconference. To obtain
teleconference call-in numbers and access
codes, to make arrangements to attend onsite, or to request special accommodations for
persons with disabilities, please register at
the SAMHSA Committees’ Web site at
https://nac.samhsa.gov/Registration/
meetingsRegistration.aspx or communicate
with DTAB’s Program Assistant, Ms. Giselle
Hersh (see contact information below).
SAMHSA would like to ensure that
advisory committee meetings proceed in an
orderly fashion, are conducted in a safe and
secure environment, that the right of free
speech is protected, and that the ability of
SAMHSA Advisory Committees to
accomplish their objectives is not disrupted.
Therefore, the following procedures will be
followed at all DTAB meetings:
• Attendees are subject to security
screening, including identification (driver’s
license) review, metal detector screening, and
inspection of briefcases, packages, etc. Each
attendee will be issued a security badge that
must be worn at all times while in the
building.
• Any interested person who wishes to be
assured of the right to make an oral
presentation during the Public Comment
portion of the DTAB meeting must register
with Ms. Hersh before the meeting.
• Those who have not registered before the
meeting will only be invited to speak at the
discretion of the Chair and should submit
their request to the Designated Federal
Official on the day of the meeting.
• Public Comment participants who are
designated to speak may be questioned only
by the Chair or DTAB members.
• Audience members may not present
comments or questions to DTAB members
unless recognized by the Chair.
• Attendees at the meeting are asked to
maintain order and not display behavior that
is disruptive to the meeting (i.e., shouting
from the audience, loud outbursts).
VerDate Nov<24>2008
18:05 Feb 18, 2010
Jkt 220001
• We ask that attendees not approach the
DTAB table area during the meeting without
permission from the Chair or the Designated
Federal Official.
• The DTAB Chair or Designated Federal
Official will note on the record any
disruptive behavior and will ask the person
to cease the behavior or else leave the
meeting room.
Substantive program information, a
summary of the meeting, and a roster of
DTAB members may be obtained as soon as
possible after the meeting, either by accessing
the SAMHSA Committee Web site, https://
www.nac.samhsa.gov/DTAB/meetings.aspx,
or by contacting Ms. Hersh. The transcript for
the meeting will also be available on the
SAMHSA Committee Web site within three
weeks after the meeting.
Committee Name: Substance Abuse and
Mental Health Services Administration, Drug
Testing Advisory Board.
Date/Time/Type: March 8, 2010 from 10
a.m. to 4:45 p.m. EST: Open.
Place: Sugarloaf and Seneca Conference
Rooms, 1 Choke Cherry Road, Rockville,
Maryland 20857.
Contacts:
Ms. Giselle Hersh, Program Assistant,
SAMHSA Drug Testing Advisory Board, 1
Choke Cherry Road, Room 2–1042,
Rockville, Maryland 20857, Telephone:
240–276–2600, Fax: 240–276–2610, E-mail:
Giselle.Hersh@samhsa.hhs.gov.
Donna M. Bush, PhD, Designated Federal
Official, SAMHSA Drug Testing Advisory
Board, 1 Choke Cherry Road, Room 2–
1033, Rockville, Maryland 20857,
Telephone: 240–276–2600, Fax: 240–276–
2610.
Toian Vaughn,
Committee Management Officer, Substance
Abuse and Mental Health Services
Administration.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group, Minority Programs Review
Subcommittee B.
Date: March 8–9, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar—Washington, DC,
Washington, DC 20037.
Contact Person: Rebecca H. Johnson, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18C, Bethesda,
MD 20892, 301–594–2771,
johnsonrh@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group, Minority Programs Review
Subcommittee A.
Date: March 8, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Marriott Chevy Chase,
Chevy Chase, MD 20815.
Contact Person: Mona R. Trempe, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12, Bethesda, MD
20892, 301–594–3998,
trempemo@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
BILLING CODE 4162–20–P
Dated: February 4, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–3200 Filed 2–18–10; 8:45 am]
[FR Doc. 2010–3227 Filed 2–18–10; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
E:\FR\FM\19FEN1.SGM
19FEN1
Federal Register / Vol. 75, No. 33 / Friday, February 19, 2010 / Notices
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Changing Parental
Relationships and Child Well-Being.
Date: March 5, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Carla T. Walls, PhD,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
(301) 435–6898, wallsc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 4, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
pwalker on DSK8KYBLC1PROD with NOTICES
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Child Health and Human Development
Special Emphasis Panel, February 16,
2010, 2 p.m. to February 16, 2010, 3
p.m., National Institutes of Health, 6100
Executive Boulevard, Room 5B01,
Rockville, MD, 20852 which was
published in the Federal Register on
January 22, 2010, 75 FR 3741.
The meeting date and time have been
changed to March 10, 2010, 1 p.m. to
March 10, 2010, 3 p.m. The meeting is
closed to the public.
BILLING CODE 4140–01–P
VerDate Nov<24>2008
18:05 Feb 18, 2010
Jkt 220001
National Cancer Institute; Cancellation
of Meeting
Notice is hereby given of the
cancellation of the National Cancer
Institute Special Emphasis Panel,
February 24, 2010, 8 a.m. to February
26, 2010, 6 p.m., Gaithersburg Marriott
Washingtonian Center, 9751
Washingtonian Blvd., Gaithersburg, MD
20878 which was published in the
Federal Register on December 15, 2009,
74 FR 66367.
Dr. Wirth’s February 24–26, 2010
meeting has been cancelled.
Dated: February 8, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–3206 Filed 2–18–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Health, Behavior, and Context
Subcommittee.
Date: February 22, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Michele C. HindiAlexander, PhD, Division of Scientific
Review, National Institutes of Health, Eunice
Kennedy Shriver, National Institute For
Child Health & Development, 6100 Executive
PO 00000
Frm 00048
Fmt 4703
Boulevard, Room 5B01, Bethesda, MD
20812–7510, (301) 435–8382,
hindialm@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 4, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–3202 Filed 2–18–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
BILLING CODE 4140–01–P
[FR Doc. 2010–3203 Filed 2–18–10; 8:45 am]
National Institutes of Health
National Institutes of Health
[FR Doc. 2010–3201 Filed 2–18–10; 8:45 am]
Dated: February 4, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
7485
Sfmt 4703
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review K08, F31.
Date: March 2, 2010.
Time: 12 p.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Four Points by Sheraton Washington
DC Downtown, 1201 K Street, NW.,
Washington, DC 20005.
Contact Person: Mary Kelly, Scientific
Review Officer, Scientific Review Branch,
National Inst of Dental & Craniofacial
Research, NIH 6701 Democracy Blvd., Room
672, MSC 4878, Bethesda, MD 20892–4878,
301–594–4809, mary_kelly@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
E:\FR\FM\19FEN1.SGM
19FEN1
]]>Agencies
[Federal Register Volume 75, Number 33 (Friday, February 19, 2010)]
[Notices]
[Pages 7484-7485]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-3201]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial
[[Page 7485]]
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Changing Parental Relationships
and Child Well-Being.
Date: March 5, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Room 5B01, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Carla T. Walls, PhD, Scientific Review Officer,
Division of Scientific Review, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892, (301) 435-6898,
wallsc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 4, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-3201 Filed 2-18-10; 8:45 am]
BILLING CODE 4140-01-P
